Preventive Asthma Drug Market Outlook 2020
Format : Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Dec, 2015| No. of Pages : 45
List of Figures:
Figure 3-1: Diagnostic Flow - Chart for Asthma in Clinical Practices
Figure 5-1: Global - Preventive Asthma Drugs Market (Billion US$), 2014-2020
Figure 6-1: Global - Preventive Asthma Drugs Market by Different Types of Drugs (%), 2014
Figure 6-2: Global - Preventive Asthma Drugs Market by Geography (%), 2014
Figure 8-1: Share of Major Players in Preventive Asthma Drugs Market (%), 2014
Figure 8-2: Glaxosmithkline Plc - Revenue by Geographical Regions (%), 2014
Figure 8-3: Astrazeneca - Revenue by Geographical Regions (%), 2014
Figure 8-4: Merck - Revenue by Geographical Regions (%), 2014
Figure 8-5: Roche - Revenue by Geographical Regions (%), 2014
Figure 8-6: Novartis - Revenue by Geographical Regions (%), 2014
List of Tables:
Table 8-1: Revenues of Top Selling Preventive Asthma Drugs (Million US$), 2014
Table 8-2: Glaxosmithkline Plc - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 8-3: Astrazeneca - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 8-4: Merck - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 8-5: Roche: Revenue by Business Segments (Billion US$), 2013 & 2014
Table 8-6: Novartis - Revenue by Business Segments (Billion US$), 2013 & 2014